Can interstitial brachytherapy compete with external beam radiotherapy in breast cancer? In response to Drs. Polgár, Major, Strnad, Inoue, and Guedea

Slides:

Advertisements

Similar presentations

Laurie Cuttino MD, Dorin Todor PhD, Douglas Arthur MD, Rohini George, Lynn Pacyna CMD Medical College of Virginia Campus Department of Radiation Oncology.

Advertisements

Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,

Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages (October 2014) DOI:

A Quantitative Analysis of the Relationship Between Radiation Therapy Use and Travel Time Emma Liu, MM, Pablo Santibáñez, MM, Martin L. Puterman, PhD,

125I reimplantation in patients with poor initial dosimetry after prostate brachytherapy Mira Keyes, MD, Tom Pickles, MD, Alexander Agranovich, MD, Winkle.

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate.

Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review David.

Jessica L. Conway, MD, Joseph M

Chris H. J. Terhaard, M. D. , Ph. D. , Herman Lubsen, M. D. , Ph. D

COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results.

Non-randomized comparison between definitive concurrent chemoradiotherapy and pre- operative radiotherapy followed by surgery in patients with hypopharyngeal.

Voice Quality After Treatment of Early Vocal Cord Cancer: A Randomized Trial Comparing Laser Surgery With Radiation Therapy Leena-Maija Aaltonen, MD,

The Case for Prostate Brachytherapy in the Affordable Care Act Era

Quality of Life and Toxicity From Passively Scattered and Spot-Scanning Proton Beam Therapy for Localized Prostate Cancer Thomas J. Pugh, MD, Mark F.

A Double-Blind Placebo-Controlled Randomized Clinical Trial With Magnesium Oxide to Reduce Intrafraction Prostate Motion for Prostate Cancer Radiotherapy

Pre-operative hyperfractionated radiotherapy and concurrent 5-fu/cisplatin for locally advanced esophageal cancer - the impact of 18-F-fluoro-deoxy-d-glucose.

The Use of Hormone Therapy Alone Versus Hormone Therapy and Radiation Therapy for Breast Cancer in Elderly Women: A Population-Based Study Alan M. Nichol,

Cost-Effectiveness Analysis of Stereotactic Body Radiotherapy and Radiofrequency Ablation for Medically Inoperable, Early-Stage Non–Small Cell Lung Cancer

L-Boronophenylalanine-Mediated Boron Neutron Capture Therapy for Malignant Glioma Progressing After External Beam Radiation Therapy: A Phase I Study

A Dose Escalation and Pharmacodynamic Study of Triapine and Radiation in Patients With Locally Advanced Pancreas Cancer Ludmila Katherine Martin, MD,

18Fluorodeoxyglucose PET Is Prognostic of Progression-Free and Overall Survival in Locally Advanced Pancreas Cancer Treated With Stereotactic Radiotherapy

Dose-Volume Histogram Predictors of Chronic Gastrointestinal Complications After Radical Hysterectomy and Postoperative Concurrent Nedaplatin-Based Chemoradiation.

T. Liu, J. Zhou, S. A. Woodhouse, P. B. Schiff, P. Zhang, K. S

The Pattern of Use of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer in New South Wales, Australia, 2008 to 2012 Geoff P. Delaney,

Lactate-Base 1H Magnetic Spectroscopy Does Not Predict Response and Outcomes in Patients With Stage IV Head and Neck Squamous Cell Carcinoma Q. Le, A.

Higher Biologically Effective Dose of Radiotherapy Is Associated With Improved Outcomes for Locally Advanced Non–Small Cell Lung Carcinoma Treated With.

Individualized Positron Emission Tomography–Based Isotoxic Accelerated Radiation Therapy Is Cost-Effective Compared With Conventional Radiation Therapy:

Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer Is Effective and Well Tolerated Michael D. Chuong,

Close or Positive Margins After Mastectomy for DCIS: Pattern of Relapse and Potential Indications for Radiotherapy Afshin Rashtian, M.D., Shawn Iganej,

Ductal Carcinoma In Situ With Microinvasion: Prognostic Implications, Long-Term Outcomes, and Role of Axillary Evaluation Rahul R. Parikh, M.D., Bruce.

The impact of ipsilateral breast tumor recurrence on cause specific survival in DCIS patients treated with breast conserving therapy or mastectomy C.

Jerry D Slater, M. D. , Carl J Rossi, M. D. , Les T Yonemoto, M. D

Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate.

A New Model for Imaging and Radiation Therapy Quality Assurance in the National Clinical Trials Network of the National Cancer Institute Thomas J. FitzGerald,

Obituary and Tribute to John “Jack” Francis Fowler, PhD, DSc ( )

Continuing Risk of Ipsilateral Breast Relapse After Breast-Conserving Therapy at Long- Term Follow-up Bas Kreike, M.D., Augustinus A.M. Hart, M.Sc., Tony.

Breast-conserving therapy with partial or whole breast irradiation: Ten-year results of the Budapest randomized trial Csaba Polgár, János Fodor, Tibor.

Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast.

Lifetime Increased Cancer Risk in Mice Following Exposure to Clinical Proton Beam– Generated Neutrons Leo E. Gerweck, PhD, Peigen Huang, MD, Hsiao-Ming.

Higher-Than-Conventional Radiation Doses in Localized Prostate Cancer Treatment: A Meta-analysis of Randomized, Controlled Trials Gustavo Arruda Viani,

Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases Isabelle Thibault, MD, Mikki Campbell,

Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma

Manuel J. Antunes, MD, PhD, DSc

International Journal of Radiation Oncology • Biology • Physics

Hendrik Westendorp, MSc, Tonnis T. Nuver, PhD, Carel J

Therapeutic Efficacy of Astatine-211–Labeled Trastuzumab on Radioresistant SKOV-3 Tumors in Nude Mice Stig Palm, Ph.D., Tom Bäck, Ingela Claesson, Anna.

High-Dose-Rate Brachytherapy Boost for Prostate Cancer: Comparison of Two Different Fractionation Schemes Tania Kaprealian, M.D., Vivian Weinberg, Ph.D.,

Effects of High Dose Opioids and Sedatives on Survival in Terminally Ill Cancer Patients Tatsuya Morita, MD, Junichi Tsunoda, MD, Satoshi Inoue, MD,

Evaluation of adherence to quality measures for prostate cancer radiotherapy in the United States: Results from the Quality Research in Radiation Oncology.

Prospective Assessment of Patient-Rated Symptoms Following Whole Brain Radiotherapy for Brain Metastases Edward Chow, MBBS, Lori Davis, PhD, Lori Holden,

Aynur Aktas, MD, Declan Walsh, MSc, FACP, FRCP(Edin), Bo Hu, PhD

Nivolumab Enhances the Inflammation of the Irradiation Field in Advanced Non–Small Cell Lung Cancer Hiromi Furuta, MD, PhD, Tatsuya Yoshida, MD, PhD,

Delirium in Terminal Cancer

Electronic Updates for JTO Readers

Intensity-Modulated Radiotherapy for Lung Cancer: Current Status and Future Developments Clara Chan, MD, Stephanie Lang, MSc, Carl Rowbottom, PhD, Matthias.

Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity Csaba Szalai, PhD, Gergely T. Kozma, BSc, Adrienne.

Advancing the Visibility, Impact, and Quality Metrics of Value in Health Regional Issues Dan Greenberg, PhD, Imre Boncz, MD, MSc, PhD, Habil, Ahmed Awaisu,

Cone-Beam CT-based position verification for oesophageal cancer: Evaluation of registration methods and anatomical changes during radiotherapy A. van.

Re-evaluation of the Role of Postoperative Radiotherapy and the Impact of Radiation Dose for Non–Small-Cell Lung Cancer Using the National Cancer Database

Iris Metastasis from Small-Cell Lung Cancer

Role of Postoperative Radiotherapy in Nonlocalized Thymoma

Gemcitabine in Brief versus Prolonged Low-Dose Infusion, both Combined with Cisplatin, for Advanced Non-small Cell Lung Cancer: A Randomized Phase II.

Pulmonary Metastasectomy in Breast Cancer

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Reporting of Funding Sources and Conflict of Interest in the Supportive and Palliative Oncology Literature David Hui, MD, MSc, FRCPC, Akhila Reddy, MD,

Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?

Outcome of Multimodality Treatment for 188 Cases of Type B3 Thymoma

Associations Between Physical Activity and Quality of Life in Cancer Patients Receiving Palliative Care: A Pilot Survey Sonya S. Lowe, MD, MSc, Sharon.

Stereotactic Body Radiotherapy for Central Lung Tumors

Robert Comis, MD, The Passing of a “Lung Man”

Presentation transcript:

Can interstitial brachytherapy compete with external beam radiotherapy in breast cancer? In response to Drs. Polgár, Major, Strnad, Inoue, and Guedea Olga Ésik, MD, PhD, DSc, Zsuzsa Póti, MD, Csaba Nemeskéri, MD, Árpád Mayer, MD, PhD, Gábor Szalai, MD, Géza Sáfrány, MD, PhD, Lajos Trón, PhD, DSc, Gergely Antal, MSc, Csaba Glavák, MSc, Imre Repa, MD, PhD International Journal of Radiation Oncology • Biology • Physics Volume 60, Issue 1, Pages 343-345 (September 2004) DOI: 10.1016/j.ijrobp.2004.04.067

Fig. 1 (a) Photographic and (b) mammographic picture of a breast after accelerated partial breast irradiation using high-dose-rate technique (courtesy of Dr. Gábor Szalai). International Journal of Radiation Oncology • Biology • Physics 2004 60, 343-345DOI: (10.1016/j.ijrobp.2004.04.067)